Drug
inhaled corticosteroids (ICS)
inhaled corticosteroids (ICS) is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
100%(3 trials)
Phase Distribution
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
completed375%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruiting
Asthma Research in Children and Adolescents
NCT04480242
completed
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
NCT05402020
completed
Exacerbation Risk in Asthma
NCT05501639
completedphase_4
Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
NCT00567476
Clinical Trials (4)
Showing 4 of 4 trials
NCT04480242
Asthma Research in Children and Adolescents
NCT05402020
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
NCT05501639
Exacerbation Risk in Asthma
NCT00567476Phase 4
Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4